Tag Archives: Gregor Wolbring

Going blind when your neural implant company flirts with bankruptcy (long read)

This story got me to thinking about what happens when any kind of implant company (pacemaker, deep brain stimulator, etc.) goes bankrupt or is acquired by another company with a different business model.

As I worked on this piece, more issues were raised and the scope expanded to include prosthetics along with implants while the focus narrowed to neuro as in, neural implants and neuroprosthetics. At the same time, I found salient examples for this posting in other medical advances such as gene editing.

In sum, all references to implants and prosthetics are to neural devices and some issues are illustrated with salient examples from other medical advances (specifically, gene editing).

Definitions (for those who find them useful)

The US Food and Drug Administration defines implants and prosthetics,

Medical implants are devices or tissues that are placed inside or on the surface of the body. Many implants are prosthetics, intended to replace missing body parts. Other implants deliver medication, monitor body functions, or provide support to organs and tissues.

As for what constitutes a neural implant/neuroprosthetic, there’s this from Emily Waltz’s January 20, 2020 article (How Do Neural Implants Work? Neural implants are used for deep brain stimulation, vagus nerve stimulation, and mind-controlled prostheses) for the Institute of Electrical and Electronics Engineers (IEEE) Spectrum magazine,

A neural implant, then, is a device—typically an electrode of some kind—that’s inserted into the body, comes into contact with tissues that contain neurons, and interacts with those neurons in some way.

Now, let’s start with the recent near bankruptcy of a retinal implant company.

The company goes bust (more or less)

From a February 25, 2022 Science Friday (a National Public Radio program) posting/audio file, Note: Links have been removed,

Barbara Campbell was walking through a New York City subway station during rush hour when her world abruptly went dark. For four years, Campbell had been using a high-tech implant in her left eye that gave her a crude kind of bionic vision, partially compensating for the genetic disease that had rendered her completely blind in her 30s. “I remember exactly where I was: I was switching from the 6 train to the F train,” Campbell tells IEEE Spectrum. “I was about to go down the stairs, and all of a sudden I heard a little ‘beep, beep, beep’ sound.’”

It wasn’t her phone battery running out. It was her Argus II retinal implant system powering down. The patches of light and dark that she’d been able to see with the implant’s help vanished.

Terry Byland is the only person to have received this kind of implant in both eyes. He got the first-generation Argus I implant, made by the company Second Sight Medical Products, in his right eye in 2004, and the subsequent Argus II implant in his left 11 years later. He helped the company test the technology, spoke to the press movingly about his experiences, and even met Stevie Wonder at a conference. “[I] went from being just a person that was doing the testing to being a spokesman,” he remembers.

Yet in 2020, Byland had to find out secondhand that the company had abandoned the technology and was on the verge of going bankrupt. While his two-implant system is still working, he doesn’t know how long that will be the case. “As long as nothing goes wrong, I’m fine,” he says. “But if something does go wrong with it, well, I’m screwed. Because there’s no way of getting it fixed.”

Science Friday and the IEEE [Institute of Electrical and Electronics Engineers] Spectrum magazine collaborated to produce this story. You’ll find the audio files and the transcript of interviews with the authors and one of the implant patients in this February 25, 2022 Science Friday (a National Public Radio program) posting.

Here’s more from the February 15, 2022 IEEE Spectrum article by Eliza Strickland and Mark Harris,

Ross Doerr, another Second Sight patient, doesn’t mince words: “It is fantastic technology and a lousy company,” he says. He received an implant in one eye in 2019 and remembers seeing the shining lights of Christmas trees that holiday season. He was thrilled to learn in early 2020 that he was eligible for software upgrades that could further improve his vision. Yet in the early months of the COVID-19 pandemic, he heard troubling rumors about the company and called his Second Sight vision-rehab therapist. “She said, ‘Well, funny you should call. We all just got laid off,’ ” he remembers. She said, ‘By the way, you’re not getting your upgrades.’ ”

These three patients, and more than 350 other blind people around the world with Second Sight’s implants in their eyes, find themselves in a world in which the technology that transformed their lives is just another obsolete gadget. One technical hiccup, one broken wire, and they lose their artificial vision, possibly forever. To add injury to insult: A defunct Argus system in the eye could cause medical complications or interfere with procedures such as MRI scans, and it could be painful or expensive to remove.

The writers included some information about what happened to the business, from the February 15, 2022 IEEE Spectrum article, Note: Links have been removed,

After Second Sight discontinued its retinal implant in 2019 and nearly went out of business in 2020, a public offering in June 2021 raised US $57.5 million at $5 per share. The company promised to focus on its ongoing clinical trial of a brain implant, called Orion, that also provides artificial vision. But its stock price plunged to around $1.50, and in February 2022, just before this article was published, the company announced a proposed merger with an early-stage biopharmaceutical company called Nano Precision Medical (NPM). None of Second Sight’s executives will be on the leadership team of the new company, which will focus on developing NPM’s novel implant for drug delivery.The company’s current leadership declined to be interviewed for this article but did provide an emailed statement prior to the merger announcement. It said, in part: “We are a recognized global leader in neuromodulation devices for blindness and are committed to developing new technologies to treat the broadest population of sight-impaired individuals.”

It’s unclear what Second Sight’s proposed merger means for Argus patients. The day after the merger was announced, Adam Mendelsohn, CEO of Nano Precision Medical, told Spectrum that he doesn’t yet know what contractual obligations the combined company will have to Argus and Orion patients. But, he says, NPM will try to do what’s “right from an ethical perspective.” The past, he added in an email, is “simply not relevant to the new future.”

There may be some alternatives, from the February 15, 2022 IEEE Spectrum article (Note: Links have been removed),

Second Sight may have given up on its retinal implant, but other companies still see a need—and a market—for bionic vision without brain surgery. Paris-based Pixium Vision is conducting European and U.S. feasibility trials to see if its Prima system can help patients with age-related macular degeneration, a much more common condition than retinitis pigmentosa.

Daniel Palanker, a professor of ophthalmology at Stanford University who licensed his technology to Pixium, says the Prima implant is smaller, simpler, and cheaper than the Argus II. But he argues that Prima’s superior image resolution has the potential to make Pixium Vision a success. “If you provide excellent vision, there will be lots of patients,” he tells Spectrum. “If you provide crappy vision, there will be very few.”

Some clinicians involved in the Argus II work are trying to salvage what they can from the technology. Gislin Dagnelie, an associate professor of ophthalmology at Johns Hopkins University School of Medicine, has set up a network of clinicians who are still working with Argus II patients. The researchers are experimenting with a thermal camera to help users see faces, a stereo camera to filter out the background, and AI-powered object recognition. These upgrades are unlikely to result in commercial hardware today but could help future vision prostheses.

The writers have carefully balanced this piece so it is not an outright condemnation of the companies (Second Sight and Nano Precision), from the February 15, 2022 IEEE Spectrum article,

Failure is an inevitable part of innovation. The Argus II was an innovative technology, and progress made by Second Sight may pave the way for other companies that are developing bionic vision systems. But for people considering such an implant in the future, the cautionary tale of Argus patients left in the lurch may make a tough decision even tougher. Should they take a chance on a novel technology? If they do get an implant and find that it helps them navigate the world, should they allow themselves to depend upon it?

Abandoning the Argus II technology—and the people who use it—might have made short-term financial sense for Second Sight, but it’s a decision that could come back to bite the merged company if it does decide to commercialize a brain implant, believes Doerr.

For anyone curious about retinal implant technology (specifically the Argus II), I have a description in a June 30, 2015 posting.

Speculations and hopes for neuroprosthetics

The field of neuroprosthetics is very active. Dr Arthur Saniotis and Prof Maciej Henneberg have written an article where they speculate about the possibilities of a neuroprosthetic that may one day merge with neurons in a February 21, 2022 Nanowerk Spotlight article,

For over a generation several types of medical neuroprosthetics have been developed, which have improved the lives of thousands of individuals. For instance, cochlear implants have restored functional hearing in individuals with severe hearing impairment.

Further advances in motor neuroprosthetics are attempting to restore motor functions in tetraplegic, limb loss and brain stem stroke paralysis subjects.

Currently, scientists are working on various kinds of brain/machine interfaces [BMI] in order to restore movement and partial sensory function. One such device is the ‘Ipsihand’ that enables movement of a paralyzed hand. The device works by detecting the recipient’s intention in the form of electrical signals, thereby triggering hand movement.

Another recent development is the 12 month BMI gait neurohabilitation program that uses a visual-tactile feedback system in combination with a physical exoskeleton and EEG operated AI actuators while walking. This program has been tried on eight patients with reported improvements in lower limb movement and somatic sensation.

Surgically placed electrode implants have also reduced tremor symptoms in individuals with Parkinson’s disease.

Although neuroprosthetics have provided various benefits they do have their problems. Firstly, electrode implants to the brain are prone to degradation, necessitating new implants after a few years. Secondly, as in any kind of surgery, implanted electrodes can cause post-operative infection and glial scarring. Furthermore, one study showed that the neurobiological efficacy of an implant is dependent on the rate of speed of its insertion.

But what if humans designed a neuroprosthetic, which could bypass the medical glitches of invasive neuroprosthetics? However, instead of connecting devices to neural networks, this neuroprosthetic would directly merge with neurons – a novel step. Such a neuroprosthetic could radically optimize treatments for neurodegenerative disorders and brain injuries, and possibly cognitive enhancement [emphasis mine].

A team of three international scientists has recently designed a nanobased neuroprosthetic, which was published in Frontiers in Neuroscience (“Integration of Nanobots Into Neural Circuits As a Future Therapy for Treating Neurodegenerative Disorders“). [open access paper published in 2018]

An interesting feature of their nanobot neuroprosthetic is that it has been inspired from nature by way of endomyccorhizae – a type of plant/fungus symbiosis, which is over four hundred million years old. During endomyccorhizae, fungi use numerous threadlike projections called mycelium that penetrate plant roots, forming colossal underground networks with nearby root systems. During this process fungi take up vital nutrients while protecting plant roots from infections – a win-win relationship. Consequently, the nano-neuroprosthetic has been named ‘endomyccorhizae ligand interface’, or ‘ELI’ for short.

The Spotlight article goes on to describe how these nanobots might function. As for the possibility of cognitive enhancement, I wonder if that might come to be described as a form of ‘artificial intelligence’.

(Dr Arthur Saniotis and Prof Maciej Henneberg are both from the Department of Anthropology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences; and Biological Anthropology and Comparative Anatomy Research Unit, Adelaide Medical School, University of Adelaide. Abdul-Rahman Sawalma who’s listed as an author on the 2018 paper is from the Palestinian Neuroscience Initiative, Al-Quds University, Beit Hanina, Palestine.)

Saniotis and Henneberg’s Spotlight article presents an optimistic view of neuroprosthetics. It seems telling that they cite cochlear implants as a success story when it is viewed by many as ethically fraught (see the Cochlear implant Wikipedia entry; scroll down to ‘Criticism and controversy’).

Ethics and your implants

This is from an April 6, 2015 article by Luc Henry on technologist.eu,

Technologist: What are the potential consequences of accepting the “augmented human” in society?

Gregor Wolbring: There are many that we might not even envision now. But let me focus on failure and obsolescence [emphasis mine], two issues that are rarely discussed. What happens when the mechanisms fails in the middle of an action? Failure has hazardous consequences, but obsolescence has psychological ones. …. The constant surgical inter­vention needed to update the hardware may not be feasible. A person might feel obsolete if she cohabits with others using a newer version.

T. Are researchers working on prosthetics sometimes disconnected from reality?

G. W. Students engaged in the development of prosthetics have to learn how to think in societal terms and develop a broader perspective. Our education system provides them with a fascination for clever solutions to technological challenges but not with tools aiming at understanding the consequences, such as whether their product might increase or decrease social justice.

Wolbring is a professor at the University of Calgary’s Cumming School of Medicine (profile page) who writes on social issues to do with human enhancement/ augmentation. As well,

Some of his areas of engagement are: ability studies including governance of ability expectations, disability studies, governance of emerging and existing sciences and technologies (e.g. nanoscale science and technology, molecular manufacturing, aging, longevity and immortality, cognitive sciences, neuromorphic engineering, genetics, synthetic biology, robotics, artificial intelligence, automatization, brain machine interfaces, sensors), impact of science and technology on marginalized populations, especially people with disabilities he governance of bodily enhancement, sustainability issues, EcoHealth, resilience, ethics issues, health policy issues, human rights and sport.

He also maintains his own website here.

Not just startups

I’d classify Second Sight as a tech startup company and they have a high rate of failure, which may not have been clear to the patients who had the implants. Clinical trials can present problems too as this excerpt from my September 17, 2020 posting notes,

This October 31, 2017 article by Emily Underwood for Science was revelatory,

“In 2003, neurologist Helen Mayberg of Emory University in Atlanta began to test a bold, experimental treatment for people with severe depression, which involved implanting metal electrodes deep in the brain in a region called area 25 [emphases mine]. The initial data were promising; eventually, they convinced a device company, St. Jude Medical in Saint Paul, to sponsor a 200-person clinical trial dubbed BROADEN.

This month [October 2017], however, Lancet Psychiatry reported the first published data on the trial’s failure. The study stopped recruiting participants in 2012, after a 6-month study in 90 people failed to show statistically significant improvements between those receiving active stimulation and a control group, in which the device was implanted but switched off.

… a tricky dilemma for companies and research teams involved in deep brain stimulation (DBS) research: If trial participants want to keep their implants [emphases mine], who will take responsibility—and pay—for their ongoing care? And participants in last week’s meeting said it underscores the need for the growing corps of DBS researchers to think long-term about their planned studies.”

Symbiosis can be another consequence, as mentioned in my September 17, 2020 posting,

From a July 24, 2019 article by Liam Drew for Nature Outlook: The brain,

“It becomes part of you,” Patient 6 said, describing the technology that enabled her, after 45 years of severe epilepsy, to halt her disabling seizures. Electrodes had been implanted on the surface of her brain that would send a signal to a hand-held device when they detected signs of impending epileptic activity. On hearing a warning from the device, Patient 6 knew to take a dose of medication to halt the coming seizure.

“You grow gradually into it and get used to it, so it then becomes a part of every day,” she told Frederic Gilbert, an ethicist who studies brain–computer interfaces (BCIs) at the University of Tasmania in Hobart, Australia. “It became me,” she said. [emphasis mine]

Symbiosis is a term, borrowed from ecology, that means an intimate co-existence of two species for mutual advantage. As technologists work towards directly connecting the human brain to computers, it is increasingly being used to describe humans’ potential relationship with artificial intelligence. [emphasis mine]

It’s complicated

For a lot of people these devices are or could be life-changing. At the same time, there are a number of different issues related to implants/prosthetics; the following is not an exhaustive list. As Wolbring notes, issues that we can’t begin to imagine now are likely to emerge as these medical advances become more ubiquitous.

Ability/disability?

Assistive technologies are almost always portrayed as helpful. For example, a cochlear implant gives people without hearing the ability to hear. The assumption is that this is always a good thing—unless you’re a deaf person who wants to define the problem a little differently. Who gets to decide what is good and ‘normal’ and what is desirable?

While the cochlear implant is the most extreme example I can think of, there are variations of these questions throughout the ‘disability’ communities.

Also, as Wolbring notes in his interview with the Technologist.eu, the education system tends to favour technological solutions which don’t take social issues into account. Wolbring cites social justice issues when he mentions failure and obsolescence.

Technical failures and obsolescence

The story, excerpted earlier in this posting, opened with a striking example of a technical failure at an awkward moment; a blind woman depending on her retinal implant loses all sight as she maneuvers through a subway station in New York City.

Aside from being an awful way to find out the company supplying and supporting your implant is in serious financial trouble and can’t offer assistance or repair, the failure offers a preview of what could happen as implants and prosthetics become more commonly used.

Keeping up/fomo (fear of missing out)/obsolescence

It used to be called ‘keeping up with the Joneses, it’s the practice of comparing yourself and your worldly goods to someone else(‘s) and then trying to equal what they have or do better. Usually, people want to have more and better than the mythical Joneses.

These days, the phenomenon (which has been expanded to include social networking) is better known as ‘fomo’ or fear of missing out (see the Fear of missing out Wikipedia entry).

Whatever you want to call it, humanity’s competitive nature can be seen where technology is concerned. When I worked in technology companies, I noticed that hardware and software were sometimes purchased for features that were effectively useless to us. But, not upgrading to a newer version was unthinkable.

Call it fomo or ‘keeping up with the Joneses’, it’s a powerful force and when people (and even companies) miss out or can’t keep up, it can lead to a sense of inferiority in the same way that having an obsolete implant or prosthetic could.

Social consequences

Could there be a neural implant/neuroprosthetic divide? There is already a digital divide (from its Wikipedia entry),

The digital divide is a gap between those who have access to new technology and those who do not … people without access to the Internet and other ICTs [information and communication technologies] are at a socio-economic disadvantage because they are unable or less able to find and apply for jobs, shop and sell online, participate democratically, or research and learn.

After reading Wolbring’s comments, it’s not hard to imagine a neural implant/neuroprosthetic divide with its attendant psychological and social consequences.

What kind of human am I?

There are other issues as noted in my September 17, 2020 posting. I’ve already mentioned ‘patient 6’, the woman who developed a symbiotic relationship with her brain/computer interface. This is how the relationship ended,

… He [Frederic Gilbert, ethicist] is now preparing a follow-up report on Patient 6. The company that implanted the device in her brain to help free her from seizures went bankrupt. The device had to be removed.

… Patient 6 cried as she told Gilbert about losing the device. … “I lost myself,” she said.

“It was more than a device,” Gilbert says. “The company owned the existence of this new person.”

Above human

The possibility that implants will not merely restore or endow someone with ‘standard’ sight or hearing or motion or … but will augment or improve on nature was broached in this May 2, 2013 posting, More than human—a bionic ear that extends hearing beyond the usual frequencies and is one of many in the ‘Human Enhancement’ category on this blog.

More recently, Hugh Herr, an Associate Professor at the Massachusetts Institute of Technology (MIT), leader of the Biomechatronics research group at MIT’s Media Lab, a double amputee, and prosthetic enthusiast, starred in the recent (February 23, 2022) broadcast of ‘Augmented‘ on the Public Broadcasting Service (PBS) science programme, Nova.

I found ‘Augmented’ a little offputting as it gave every indication of being an advertisement for Herr’s work in the form of a hero’s journey. I was not able to watch more than 10 mins. This preview gives you a pretty good idea of what it was like although the part in ‘Augmented, where he says he’d like to be a cyborg hasn’t been included,

At a guess, there were a few talking heads (taking up from 10%-20% of the running time) who provided some cautionary words to counterbalance the enthusiasm in the rest of the programme. It’s a standard approach designed to give the impression that both sides of a question are being recognized. The cautionary material is usually inserted past the 1/2 way mark while leaving several minutes at the end for returning to the more optimistic material.

In a February 2, 2010 posting I have excerpts from an article featuring quotes from Herr that I still find startling,

Written by Paul Hochman for Fast Company, Bionic Legs, iLimbs, and Other Super-Human Prostheses [ETA March 23, 2022: an updated version of the article is now on Genius.com] delves further into the world where people may be willing to trade a healthy limb for a prosthetic. From the article,

There are many advantages to having your leg amputated.

Pedicure costs drop 50% overnight. A pair of socks lasts twice as long. But Hugh Herr, the director of the Biomechatronics Group at the MIT Media Lab, goes a step further. “It’s actually unfair,” Herr says about amputees’ advantages over the able-bodied. “As tech advancements in prosthetics come along, amputees can exploit those improvements. They can get upgrades. A person with a natural body can’t.”

Herr is not the only one who favours prosthetics (also from the Hochman article),

This influx of R&D cash, combined with breakthroughs in materials science and processor speed, has had a striking visual and social result: an emblem of hurt and loss has become a paradigm of the sleek, modern, and powerful. Which is why Michael Bailey, a 24-year-old student in Duluth, Georgia, is looking forward to the day when he can amputate the last two fingers on his left hand.

“I don’t think I would have said this if it had never happened,” says Bailey, referring to the accident that tore off his pinkie, ring, and middle fingers. “But I told Touch Bionics I’d cut the rest of my hand off if I could make all five of my fingers robotic.”

But Bailey is most surprised by his own reaction. “When I’m wearing it, I do feel different: I feel stronger. As weird as that sounds, having a piece of machinery incorporated into your body, as a part of you, well, it makes you feel above human.[emphasis mine] It’s a very powerful thing.”

My September 17, 2020 posting touches on more ethical and social issues including some of those surrounding consumer neurotechnologies or brain-computer interfaces (BCI). Unfortunately, I don’t have space for these issues here.

As for Paul Hochman’s article, Bionic Legs, iLimbs, and Other Super-Human Prostheses, now on Genius.com, it has been updated.

Money makes the world go around

Money and business practices have been indirectly referenced (for the most part) up to now in this posting. The February 15, 2022 IEEE Spectrum article and Hochman’s article, Bionic Legs, iLimbs, and Other Super-Human Prostheses, cover two aspects of the money angle.

In the IEEE Spectrum article, a tech start-up company, Second Sight, ran into financial trouble and is acquired by a company that has no plans to develop Second Sight’s core technology. The people implanted with the Argus II technology have been stranded as were ‘patient 6’ and others participating in the clinical trial described in the July 24, 2019 article by Liam Drew for Nature Outlook: The brain mentioned earlier in this posting.

I don’t know anything about the business bankruptcy mentioned in the Drew article but one of the business problems described in the IEEE Spectrum article suggests that Second Sight was founded before answering a basic question, “What is the market size for this product?”

On 18 July 2019, Second Sight sent Argus patients a letter saying it would be phasing out the retinal implant technology to clear the way for the development of its next-generation brain implant for blindness, Orion, which had begun a clinical trial with six patients the previous year. …

“The leadership at the time didn’t believe they could make [the Argus retinal implant] part of the business profitable,” Greenberg [Robert Greenberg, Second Sight co-founder] says. “I understood the decision, because I think the size of the market turned out to be smaller than we had thought.”

….

The question of whether a medical procedure or medicine can be profitable (or should the question be sufficiently profitable?) was referenced in my April 26, 2019 posting in the context of gene editing and personalized medicine

Edward Abrahams, president of the Personalized Medicine Coalition (US-based), advocates for personalized medicine while noting in passing, market forces as represented by Goldman Sachs in his May 23, 2018 piece for statnews.com (Note: A link has been removed),

Goldman Sachs, for example, issued a report titled “The Genome Revolution.” It argues that while “genome medicine” offers “tremendous value for patients and society,” curing patients may not be “a sustainable business model.” [emphasis mine] The analysis underlines that the health system is not set up to reap the benefits of new scientific discoveries and technologies. Just as we are on the precipice of an era in which gene therapies, gene-editing, and immunotherapies promise to address the root causes of disease, Goldman Sachs says that these therapies have a “very different outlook with regard to recurring revenue versus chronic therapies.”

The ‘Glybera’ story in my July 4, 2019 posting (scroll down about 40% of the way) highlights the issue with “recurring revenue versus chronic therapies,”

Kelly Crowe in a November 17, 2018 article for the CBC (Canadian Broadcasting Corporation) news writes about Glybera,

It is one of this country’s great scientific achievements.

“The first drug ever approved that can fix a faulty gene.

It’s called Glybera, and it can treat a painful and potentially deadly genetic disorder with a single dose — a genuine made-in-Canada medical breakthrough.

But most Canadians have never heard of it.

Here’s my summary (from the July 4, 2019 posting),

It cost $1M for a single treatment and that single treatment is good for at least 10 years.

Pharmaceutical companies make their money from repeated use of their medicaments and Glybera required only one treatment so the company priced it according to how much they would have gotten for repeated use, $100,000 per year over a 10 year period. The company was not able to persuade governments and/or individuals to pay the cost

In the end, 31 people got the treatment, most of them received it for free through clinical trials.

For rich people only?

Megan Devlin’s March 8, 2022 article for the Daily Hive announces a major research investment into medical research (Note: A link has been removed),

Vancouver [Canada] billionaire Chip Wilson revealed Tuesday [March 8, 2022] that he has a rare genetic condition that causes his muscles to waste away, and announced he’s spending $100 million on research to find a cure.

His condition is called facio-scapulo-humeral muscular dystrophy, or FSHD for short. It progresses rapidly in some people and more slowly in others, but is characterized by progressive muscle weakness starting the the face, the neck, shoulders, and later the lower body.

“I’m out for survival of my own life,” Wilson said.

“I also have the resources to do something about this which affects so many people in the world.”

Wilson hopes the $100 million will produce a cure or muscle-regenerating treatment by 2027.

“This could be one of the biggest discoveries of all time, for humankind,” Wilson said. “Most people lose muscle, they fall, and they die. If we can keep muscle as we age this can be a longevity drug like we’ve never seen before.”

According to rarediseases.org, FSHD affects between four and 10 people out of every 100,000 [emphasis mine], Right now, therapies are limited to exercise and pain management. There is no way to stall or reverse the disease’s course.

Wilson is best known for founding athleisure clothing company Lululemon. He also owns the most expensive home in British Columbia, a $73 million mansion in Vancouver’s Kitsilano neighbourhood.

Let’s see what the numbers add up to,

4 – 10 people out of 100,000

40 – 100 people out of 1M

1200 – 3,000 people out of 30M (let’s say this is Canada’s population)\

12,000 – 30,000 people out of 300M (let’s say this is the US’s population)

42,000 – 105,000 out of 1.115B (let’s say this is China’s population)

The rough total comes to 55,200 to 138,000 people between three countries with a combined population total of 1.445B. Given how business currently operates, it seems unlikely that any company will want to offer Wilson’s hoped for medical therapy although he and possibly others may benefit from a clinical trial.

Should profit or wealth be considerations?

The stories about the patients with the implants and the patients who need Glybera are heartbreaking and point to a question not often asked when medical therapies and medications are developed. Is the profit model the best choice and, if so, how much profit?

I have no answer to that question but I wish it was asked by medical researchers and policy makers.

As for wealthy people dictating the direction for medical research, I don’t have answers there either. I hope the research will yield applications and/or valuable information for more than Wilson’s disease.

It’s his money after all

Wilson calls his new venture, SolveFSHD. It doesn’t seem to be affiliated with any university or biomedical science organization and it’s not clear how the money will be awarded (no programmes, no application procedure, no panel of experts). There are three people on the team, Eva R. Chin, scientist and executive director, Chip Wilson, SolveFSHD founder/funder, and FSHD patient, and Neil Camarta, engineer, executive (fossil fuels and clean energy), and FSHD patient. There’s also a Twitter feed (presumably for the latest updates): https://twitter.com/SOLVEFSHD.

Perhaps unrelated but intriguing is news about a proposed new building in Kenneth Chan’s March 31, 2022 article for the Daily Hive,

Low Tide Properties, the real estate arm of Lululemon founder Chip Wilson [emphasis mine], has submitted a new development permit application to build a 148-ft-tall, eight-storey, mixed-use commercial building in the False Creek Flats of Vancouver.

The proposal, designed by local architectural firm Musson Cattell Mackey Partnership, calls for 236,000 sq ft of total floor area, including 105,000 sq ft of general office space, 102,000 sq ft of laboratory space [emphasis mine], and 5,000 sq ft of ground-level retail space. An outdoor amenity space for building workers will be provided on the rooftop.

[next door] The 2001-built, five-storey building at 1618 Station Street immediately to the west of the development site is also owned by Low Tide Properties [emphasis mine]. The Ferguson, the name of the existing building, contains about 79,000 sq ft of total floor area, including 47,000 sq ft of laboratory space and 32,000 sq ft of general office space. Biotechnology company Stemcell technologies [STEMCELL] Technologies] is the anchor tenant [emphasis mine].

I wonder if this proposed new building will house SolveFSHD and perhaps other FSHD-focused enterprises. The proximity of STEMCELL Technologies could be quite convenient. In any event, $100M will buy a lot (pun intended).

The end

Issues I’ve described here in the context of neural implants/neuroprosthetics and cutting edge medical advances are standard problems not specific to these technologies/treatments:

  • What happens when the technology fails (hopefully not at a critical moment)?
  • What happens when your supplier goes out of business or discontinues the products you purchase from them?
  • How much does it cost?
  • Who can afford the treatment/product? Will it only be for rich people?
  • Will this technology/procedure/etc. exacerbate or create new social tensions between social classes, cultural groups, religious groups, races, etc.?

Of course, having your neural implant fail suddenly in the middle of a New York City subway station seems a substantively different experience than having your car break down on the road.

There are, of course, there are the issues we can’t yet envision (as Wolbring notes) and there are issues such as symbiotic relationships with our implants and/or feeling that you are “above human.” Whether symbiosis and ‘implant/prosthetic superiority’ will affect more than a small number of people or become major issues is still to be determined.

There’s a lot to be optimistic about where new medical research and advances are concerned but I would like to see more thoughtful coverage in the media (e.g., news programmes and documentaries like ‘Augmented’) and more thoughtful comments from medical researchers.

Of course, the biggest issue I’ve raised here is about the current business models for health care products where profit is valued over people’s health and well-being. it’s a big question and I don’t see any definitive answers but the question put me in mind of this quote (from a September 22, 2020 obituary for US Supreme Court Justice Ruth Bader Ginsburg by Irene Monroe for Curve),

Ginsburg’s advocacy for justice was unwavering and showed it, especially with each oral dissent. In another oral dissent, Ginsburg quoted a familiar Martin Luther King Jr. line, adding her coda:” ‘The arc of the universe is long, but it bends toward justice,’” but only “if there is a steadfast commitment to see the task through to completion.” …

Martin Luther King Jr. popularized and paraphrased the quote (from a January 18, 2018 article by Mychal Denzel Smith for Huffington Post),

His use of the quote is best understood by considering his source material. “The arc of the moral universe is long, but it bends toward justice” is King’s clever paraphrasing of a portion of a sermon delivered in 1853 by the abolitionist minister Theodore Parker. Born in Lexington, Massachusetts, in 1810, Parker studied at Harvard Divinity School and eventually became an influential transcendentalist and minister in the Unitarian church. In that sermon, Parker said: “I do not pretend to understand the moral universe. The arc is a long one. My eye reaches but little ways. I cannot calculate the curve and complete the figure by experience of sight. I can divine it by conscience. And from what I see I am sure it bends toward justice.”

I choose to keep faith that people will get the healthcare products they need and that all of us need to keep working at making access more fair.

A look back at 2020 on this blog and a welcome to 2021

Things past

A year later i still don’t know what came over me but I got the idea that I could write a 10-year (2010 – 2019) review of science culture in Canada during the last few days of 2019. Somehow two and half months later, I managed to publish my 25,000+ multi-part series.

Plus,

Sadly, 2020 started on a somber note with this January 13, 2020 posting, In memory of those in the science, engineering, or technology communities returning to or coming to live or study in Canada on Flight PS752.

COVID-19 was mentioned and featured here a number of times throughout the year. I’m highlighting two of those postings. The first is a June 24, 2020 posting titled, Tiny sponges lure coronavirus away from lung cells. It’s a therapeutic approach that is not a vaccine but a way of neutralizing the virus. The idea is that the nanosponge is coated in the material that the virus seeks in a human cell. Once the virus locks onto the sponge, it is unable to seek out cells. If I remember rightly, the sponges along with the virus are disposed of by the body’s usual processes.

The second COVID-19 posting I’m highlighting is my first ever accepted editorial opinion by the Canadian Science Policy Centre (CSPC). I republished the piece here in a May 15, 2020 posting, which included all of my references. However, the magazine version is more attractively displayed in the CSPC Featured Editorial Series Volume 1, Issue 2, May 2020 PDF on pp. 31-2.

Artist Joseph Nechvatal reached out to me earlier this year regarding his viral symphOny (2006-2008), a 1 hour 40 minute collaborative electronic noise music symphony. It was featured in an April 7, 2020 posting which seemed strangely à propos during a pandemic even though the work was focused on viral artificial life. You can access it for free https://archive.org/details/ViralSymphony but the Internet Archive where this is stored is requesting donations.

Also on a vaguely related COVID-19 note, there’s my December 7, 2020 posting titled, Digital aromas? And a potpourri of ‘scents and sensibility’. As any regular readers may know, I have a longstanding interest in scent and fragrances. The COVID-19 part of the posting (it’s not about losing your sense of smell) is in the subsection titled, Smelling like an old book. Apparently some folks are missing the smell of bookstores and Powell’s books have responded to that need with a new fragrance.

For anyone who may have missed it, I wrote an update of the CRISPR twin affair in my July 28, 2020 posting, titled, July 2020 update on Dr. He Jiankui (the CRISPR twins) situation.

Finishing off with 2020, I wrote a commentary (mostly focused on the Canada chapter) about a book titled, Communicating Science: A Global Perspective in my December 10, 2020 posting. The book offers science communication perspectives from 39 different countries.

Things future

I have no doubt there will be delights ahead but as they are in the realm of discovery and, at this point, they are currently unknown.

My future plans include a posting about trust and governance. This has come about since writing my Dec. 29, 2020 posting titled, “Governments need to tell us when and how they’re using AI (artificial intelligence) algorithms to make decisions” and stumbling across a reference to a December 15, 2020 article by Dr. Andrew Maynard titled, Why Trustworthiness Matters in Building Global Futures. Maynard’s focus was on a newly published report titled, Trust & Tech Governance.

I will also be considering the problematic aspects of science communication and my own shortcomings. On the heels of reading more than usually forthright discussions of racism in Canada across multiple media platforms, I was horrified to discover I had featured, without any caveats, work by a man who was deeply problematic with regard to his beliefs about race. He was a eugenicist, as well as, a zoologist, naturalist, philosopher, physician, professor, marine biologist, and artist who coined many terms in biology, including ecology, phylum, phylogeny, and Protista; see his Wikipedia entry.

A Dec. 23, 2020 news release on EurekAlert (Scientists at Tel Aviv University develop new gene therapy for deafness) and a December 2020 article by Sarah Zhang for The Atlantic about prenatal testing and who gets born have me wanting to further explore the field of how genetic testing and therapies will affect our concepts of ‘normality’. Fingers crossed I’ll be able to get Dr. Gregor Wolbring to answer a few questions for publication here. (Gregor is a tenured associate professor [in Alberta, Canada] at the University of Calgary’s Cumming School of Medicine and a scholar in the field of ‘ableism’. He is deeply knowledgeable about notions of ability vs disability.)

As 2021 looms, I’m hopeful that I’ll be featuring more art/sci (or sciart) postings, which is my segue to a more hopeful note about 2021 will bring us,

The Knobbed Russet has a rough exterior, with creamy insides. Photo courtesy of William Mullan.

It’s an apple! This is one of the many images embedded in Annie Ewbank’s January 6, 2020 article about rare and beautiful apples for Atlas Obscura (featured on getpocket.com),

In early 2020, inside a bright Brooklyn gallery that is plastered in photographs of apples, William Mullan is being besieged with questions.

A writer is researching apples for his novel set in post-World War II New York. An employee of a fruit-delivery company, who covetously eyes the round table on which Mullan has artfully arranged apples, asks where to buy his artwork.

But these aren’t your Granny Smith’s apples. A handful of Knobbed Russets slumping on the table resemble rotting masses. Despite their brown, wrinkly folds, they’re ripe, with clean white interiors. Another, the small Roberts Crab, when sliced by Mullan through the middle to show its vermillion flesh, looks less like an apple than a Bing cherry. The entire lineup consists of apples assembled by Mullan, who, by publishing his fruit photographs in a book and on Instagram, is putting the glorious diversity of apples in the limelight.

Do go and enjoy! Happy 2021!

Turning brain-controlled wireless electronic prostheses into reality plus some ethical points

Researchers at Stanford University (California, US) believe they have a solution for a problem with neuroprosthetics (Note: I have included brief comments about neuroprosthetics and possible ethical issues at the end of this posting) according an August 5, 2020 news item on ScienceDaily,

The current generation of neural implants record enormous amounts of neural activity, then transmit these brain signals through wires to a computer. But, so far, when researchers have tried to create wireless brain-computer interfaces to do this, it took so much power to transmit the data that the implants generated too much heat to be safe for the patient. A new study suggests how to solve his problem — and thus cut the wires.

Caption: Photo of a current neural implant, that uses wires to transmit information and receive power. New research suggests how to one day cut the wires. Credit: Sergey Stavisky

An August 3, 2020 Stanford University news release (also on EurekAlert but published August 4, 2020) by Tom Abate, which originated the news item, details the problem and the proposed solution,

Stanford researchers have been working for years to advance a technology that could one day help people with paralysis regain use of their limbs, and enable amputees to use their thoughts to control prostheses and interact with computers.

The team has been focusing on improving a brain-computer interface, a device implanted beneath the skull on the surface of a patient’s brain. This implant connects the human nervous system to an electronic device that might, for instance, help restore some motor control to a person with a spinal cord injury, or someone with a neurological condition like amyotrophic lateral sclerosis, also called Lou Gehrig’s disease.

The current generation of these devices record enormous amounts of neural activity, then transmit these brain signals through wires to a computer. But when researchers have tried to create wireless brain-computer interfaces to do this, it took so much power to transmit the data that the devices would generate too much heat to be safe for the patient.

Now, a team led by electrical engineers and neuroscientists Krishna Shenoy, PhD, and Boris Murmann, PhD, and neurosurgeon and neuroscientist Jaimie Henderson, MD, have shown how it would be possible to create a wireless device, capable of gathering and transmitting accurate neural signals, but using a tenth of the power required by current wire-enabled systems. These wireless devices would look more natural than the wired models and give patients freer range of motion.

Graduate student Nir Even-Chen and postdoctoral fellow Dante Muratore, PhD, describe the team’s approach in a Nature Biomedical Engineering paper.

The team’s neuroscientists identified the specific neural signals needed to control a prosthetic device, such as a robotic arm or a computer cursor. The team’s electrical engineers then designed the circuitry that would enable a future, wireless brain-computer interface to process and transmit these these carefully identified and isolated signals, using less power and thus making it safe to implant the device on the surface of the brain.

To test their idea, the researchers collected neuronal data from three nonhuman primates and one human participant in a (BrainGate) clinical trial.

As the subjects performed movement tasks, such as positioning a cursor on a computer screen, the researchers took measurements. The findings validated their hypothesis that a wireless interface could accurately control an individual’s motion by recording a subset of action-specific brain signals, rather than acting like the wired device and collecting brain signals in bulk.

The next step will be to build an implant based on this new approach and proceed through a series of tests toward the ultimate goal.

Here’s a link to and a citation for the paper,

Power-saving design opportunities for wireless intracortical brain–computer interfaces by Nir Even-Chen, Dante G. Muratore, Sergey D. Stavisky, Leigh R. Hochberg, Jaimie M. Henderson, Boris Murmann & Krishna V. Shenoy. Nature Biomedical Engineering (2020) DOI: https://doi.org/10.1038/s41551-020-0595-9 Published: 03 August 2020

This paper is behind a paywall.

Comments about ethical issues

As I found out while investigating, ethical issues in this area abound. My first thought was to look at how someone with a focus on ability studies might view the complexities.

My ‘go to’ resource for human enhancement and ethical issues is Gregor Wolbring, an associate professor at the University of Calgary (Alberta, Canada). his profile lists these areas of interest: ability studies, disability studies, governance of emerging and existing sciences and technologies (e.g. neuromorphic engineering, genetics, synthetic biology, robotics, artificial intelligence, automatization, brain machine interfaces, sensors) and more.

I can’t find anything more recent on this particular topic but I did find an August 10, 2017 essay for The Conversation where he comments on technology and human enhancement ethical issues where the technology is gene-editing. Regardless, he makes points that are applicable to brain-computer interfaces (human enhancement), Note: Links have been removed),

Ability expectations have been and still are used to disable, or disempower, many people, not only people seen as impaired. They’ve been used to disable or marginalize women (men making the argument that rationality is an important ability and women don’t have it). They also have been used to disable and disempower certain ethnic groups (one ethnic group argues they’re smarter than another ethnic group) and others.

A recent Pew Research survey on human enhancement revealed that an increase in the ability to be productive at work was seen as a positive. What does such ability expectation mean for the “us” in an era of scientific advancements in gene-editing, human enhancement and robotics?

Which abilities are seen as more important than others?

The ability expectations among “us” will determine how gene-editing and other scientific advances will be used.

And so how we govern ability expectations, and who influences that governance, will shape the future. Therefore, it’s essential that ability governance and ability literacy play a major role in shaping all advancements in science and technology.

One of the reasons I find Gregor’s commentary so valuable is that he writes lucidly about ability and disability as concepts and poses what can be provocative questions about expectations and what it is to be truly abled or disabled. You can find more of his writing here on his eponymous (more or less) blog.

Ethics of clinical trials for testing brain implants

This October 31, 2017 article by Emily Underwood for Science was revelatory,

In 2003, neurologist Helen Mayberg of Emory University in Atlanta began to test a bold, experimental treatment for people with severe depression, which involved implanting metal electrodes deep in the brain in a region called area 25 [emphases mine]. The initial data were promising; eventually, they convinced a device company, St. Jude Medical in Saint Paul, to sponsor a 200-person clinical trial dubbed BROADEN.

This month [October 2017], however, Lancet Psychiatry reported the first published data on the trial’s failure. The study stopped recruiting participants in 2012, after a 6-month study in 90 people failed to show statistically significant improvements between those receiving active stimulation and a control group, in which the device was implanted but switched off.

… a tricky dilemma for companies and research teams involved in deep brain stimulation (DBS) research: If trial participants want to keep their implants [emphases mine], who will take responsibility—and pay—for their ongoing care? And participants in last week’s meeting said it underscores the need for the growing corps of DBS researchers to think long-term about their planned studies.

… participants bear financial responsibility for maintaining the device should they choose to keep it, and for any additional surgeries that might be needed in the future, Mayberg says. “The big issue becomes cost [emphasis mine],” she says. “We transition from having grants and device donations” covering costs, to patients being responsible. And although the participants agreed to those conditions before enrolling in the trial, Mayberg says she considers it a “moral responsibility” to advocate for lower costs for her patients, even it if means “begging for charity payments” from hospitals. And she worries about what will happen to trial participants if she is no longer around to advocate for them. “What happens if I retire, or get hit by a bus?” she asks.

There’s another uncomfortable possibility: that the hypothesis was wrong [emphases mine] to begin with. A large body of evidence from many different labs supports the idea that area 25 is “key to successful antidepressant response,” Mayberg says. But “it may be too simple-minded” to think that zapping a single brain node and its connections can effectively treat a disease as complex as depression, Krakauer [John Krakauer, a neuroscientist at Johns Hopkins University in Baltimore, Maryland] says. Figuring that out will likely require more preclinical research in people—a daunting prospect that raises additional ethical dilemmas, Krakauer says. “The hardest thing about being a clinical researcher,” he says, “is knowing when to jump.”

Brain-computer interfaces, symbiosis, and ethical issues

This was the most recent and most directly applicable work that I could find. From a July 24, 2019 article by Liam Drew for Nature Outlook: The brain,

“It becomes part of you,” Patient 6 said, describing the technology that enabled her, after 45 years of severe epilepsy, to halt her disabling seizures. Electrodes had been implanted on the surface of her brain that would send a signal to a hand-held device when they detected signs of impending epileptic activity. On hearing a warning from the device, Patient 6 knew to take a dose of medication to halt the coming seizure.

“You grow gradually into it and get used to it, so it then becomes a part of every day,” she told Frederic Gilbert, an ethicist who studies brain–computer interfaces (BCIs) at the University of Tasmania in Hobart, Australia. “It became me,” she said. [emphasis mine]

Gilbert was interviewing six people who had participated in the first clinical trial of a predictive BCI to help understand how living with a computer that monitors brain activity directly affects individuals psychologically1. Patient 6’s experience was extreme: Gilbert describes her relationship with her BCI as a “radical symbiosis”.

Symbiosis is a term, borrowed from ecology, that means an intimate co-existence of two species for mutual advantage. As technologists work towards directly connecting the human brain to computers, it is increasingly being used to describe humans’ potential relationship with artificial intelligence.

Interface technologies are divided into those that ‘read’ the brain to record brain activity and decode its meaning, and those that ‘write’ to the brain to manipulate activity in specific regions and affect their function.

Commercial research is opaque, but scientists at social-media platform Facebook are known to be pursuing brain-reading techniques for use in headsets that would convert users’ brain activity into text. And neurotechnology companies such as Kernel in Los Angeles, California, and Neuralink, founded by Elon Musk in San Francisco, California, predict bidirectional coupling in which computers respond to people’s brain activity and insert information into their neural circuitry. [emphasis mine]

Already, it is clear that melding digital technologies with human brains can have provocative effects, not least on people’s agency — their ability to act freely and according to their own choices. Although neuroethicists’ priority is to optimize medical practice, their observations also shape the debate about the development of commercial neurotechnologies.

Neuroethicists began to note the complex nature of the therapy’s side effects. “Some effects that might be described as personality changes are more problematic than others,” says Maslen [Hannah Maslen, a neuroethicist at the University of Oxford, UK]. A crucial question is whether the person who is undergoing stimulation can reflect on how they have changed. Gilbert, for instance, describes a DBS patient who started to gamble compulsively, blowing his family’s savings and seeming not to care. He could only understand how problematic his behaviour was when the stimulation was turned off.

Such cases present serious questions about how the technology might affect a person’s ability to give consent to be treated, or for treatment to continue. [emphases mine] If the person who is undergoing DBS is happy to continue, should a concerned family member or doctor be able to overrule them? If someone other than the patient can terminate treatment against the patient’s wishes, it implies that the technology degrades people’s ability to make decisions for themselves. It suggests that if a person thinks in a certain way only when an electrical current alters their brain activity, then those thoughts do not reflect an authentic self.

To observe a person with tetraplegia bringing a drink to their mouth using a BCI-controlled robotic arm is spectacular. [emphasis mine] This rapidly advancing technology works by implanting an array of electrodes either on or in a person’s motor cortex — a brain region involved in planning and executing movements. The activity of the brain is recorded while the individual engages in cognitive tasks, such as imagining that they are moving their hand, and these recordings are used to command the robotic limb.

If neuroscientists could unambiguously discern a person’s intentions from the chattering electrical activity that they record in the brain, and then see that it matched the robotic arm’s actions, ethical concerns would be minimized. But this is not the case. The neural correlates of psychological phenomena are inexact and poorly understood, which means that signals from the brain are increasingly being processed by artificial intelligence (AI) software before reaching prostheses.[emphasis mine]

But, he [Philipp Kellmeyer, a neurologist and neuroethicist at the University of Freiburg, Germany] says, using AI tools also introduces ethical issues of which regulators have little experience. [emphasis mine] Machine-learning software learns to analyse data by generating algorithms that cannot be predicted and that are difficult, or impossible, to comprehend. This introduces an unknown and perhaps unaccountable process between a person’s thoughts and the technology that is acting on their behalf.

Maslen is already helping to shape BCI-device regulation. She is in discussion with the European Commission about regulations it will implement in 2020 that cover non-invasive brain-modulating devices that are sold straight to consumers. [emphases mine; Note: There is a Canadian company selling this type of product, MUSE] Maslen became interested in the safety of these devices, which were covered by only cursory safety regulations. Although such devices are simple, they pass electrical currents through people’s scalps to modulate brain activity. Maslen found reports of them causing burns, headaches and visual disturbances. She also says clinical studies have shown that, although non-invasive electrical stimulation of the brain can enhance certain cognitive abilities, this can come at the cost of deficits in other aspects of cognition.

Regarding my note about MUSE, the company is InteraXon and its product is MUSE.They advertise the product as “Brain Sensing Headbands That Improve Your Meditation Practice.” The company website and the product seem to be one entity, Choose Muse. The company’s product has been used in some serious research papers they can be found here. I did not see any research papers concerning safety issues.

Getting back to Drew’s July 24, 2019 article and Patient 6,

… He [Gilbert] is now preparing a follow-up report on Patient 6. The company that implanted the device in her brain to help free her from seizures went bankrupt. The device had to be removed.

… Patient 6 cried as she told Gilbert about losing the device. … “I lost myself,” she said.

“It was more than a device,” Gilbert says. “The company owned the existence of this new person.”

I strongly recommend reading Drew’s July 24, 2019 article in its entirety.

Finally

It’s easy to forget that in all the excitement over technologies ‘making our lives better’ that there can be a dark side or two. Some of the points brought forth in the articles by Wolbring, Underwood, and Drew confirmed my uneasiness as reasonable and gave me some specific examples of how these technologies raise new issues or old issues in new ways.

What I find interesting is that no one is using the term ‘cyborg’, which would seem quite applicable.There is an April 20, 2012 posting here titled ‘My mother is a cyborg‘ where I noted that by at lease one definition people with joint replacements, pacemakers, etc. are considered cyborgs. In short, cyborgs or technology integrated into bodies have been amongst us for quite some time.

Interestingly, no one seems to care much when insects are turned into cyborgs (can’t remember who pointed this out) but it is a popular area of research especially for military applications and search and rescue applications.

I’ve sometimes used the term ‘machine/flesh’ and or ‘augmentation’ as a description of technologies integrated with bodies, human or otherwise. You can find lots on the topic here however I’ve tagged or categorized it.

Amongst other pieces you can find here, there’s the August 8, 2016 posting, ‘Technology, athletics, and the ‘new’ human‘ featuring Oscar Pistorius when he was still best known as the ‘blade runner’ and a remarkably successful paralympic athlete. It’s about his efforts to compete against able-bodied athletes at the London Olympic Games in 2012. It is fascinating to read about technology and elite athletes of any kind as they are often the first to try out ‘enhancements’.

Gregor Wolbring has a number of essays on The Conversation looking at Paralympic athletes and their pursuit of enhancements and how all of this is affecting our notions of abilities and disabilities. By extension, one has to assume that ‘abled’ athletes are also affected with the trickle-down effect on the rest of us.

Regardless of where we start the investigation, there is a sameness to the participants in neuroethics discussions with a few experts and commercial interests deciding on how the rest of us (however you define ‘us’ as per Gregor Wolbring’s essay) will live.

This paucity of perspectives is something I was getting at in my COVID-19 editorial for the Canadian Science Policy Centre. My thesis being that we need a range of ideas and insights that cannot be culled from small groups of people who’ve trained and read the same materials or entrepreneurs who too often seem to put profit over thoughtful implementations of new technologies. (See the PDF May 2020 edition [you’ll find me under Policy Development]) or see my May 15, 2020 posting here (with all the sources listed.)

As for this new research at Stanford, it’s exciting news, which raises questions, as it offers the hope of independent movement for people diagnosed as tetraplegic (sometimes known as quadriplegic.)

Brain and machine as one (machine/flesh)

The essay on brains and machines becoming intertwined is making the rounds. First stop on my tour was its Oct. 4, 2016 appearance on the Mail & Guardian, then there was its Oct. 3, 2016 appearance on The Conversation, and finally (moving forward in time) there was its Oct. 4, 2016 appearance on the World Economic Forum website as part of their Final Frontier series.

The essay was written by Richard Jones of Sheffield University (mentioned here many times before but most recently in a Sept. 4, 2014 posting). His book ‘Soft Machines’ provided me with an important and eminently readable introduction to nanotechnology. He is a professor of physics at the University of Sheffield and here’s more from his essay (Oct. 3, 2016 on The Conversation) about brains and machines (Note: Links have been removed),

Imagine a condition that leaves you fully conscious, but unable to move or communicate, as some victims of severe strokes or other neurological damage experience. This is locked-in syndrome, when the outward connections from the brain to the rest of the world are severed. Technology is beginning to promise ways of remaking these connections, but is it our ingenuity or the brain’s that is making it happen?

Ever since an 18th-century biologist called Luigi Galvani made a dead frog twitch we have known that there is a connection between electricity and the operation of the nervous system. We now know that the signals in neurons in the brain are propagated as pulses of electrical potential, whose effects can be detected by electrodes in close proximity. So in principle, we should be able to build an outward neural interface system – that is to say, a device that turns thought into action.

In fact, we already have the first outward neural interface system to be tested in humans. It is called BrainGate and consists of an array of micro-electrodes, implanted into the part of the brain concerned with controlling arm movements. Signals from the micro-electrodes are decoded and used to control the movement of a cursor on a screen, or the motion of a robotic arm.

A crucial feature of these systems is the need for some kind of feedback. A patient must be able to see the effect of their willed patterns of thought on the movement of the cursor. What’s remarkable is the ability of the brain to adapt to these artificial systems, learning to control them better.

You can find out more about BrainGate in my May 17, 2012 posting which also features a video of a woman controlling a mechanical arm so she can drink from a cup coffee by herself for the first time in 15 years.

Jones goes on to describe the cochlear implants (although there’s no mention of the controversy; not everyone believes they’re a good idea) and retinal implants that are currently available. Jones notes this (Note Links have been removed),

The key message of all this is that brain interfaces now are a reality and that the current versions will undoubtedly be improved. In the near future, for many deaf and blind people, for people with severe disabilities – including, perhaps, locked-in syndrome – there are very real prospects that some of their lost capabilities might be at least partially restored.

Until then, our current neural interface systems are very crude. One problem is size; the micro-electrodes in use now, with diameters of tens of microns, may seem tiny, but they are still coarse compared to the sub-micron dimensions of individual nerve fibres. And there is a problem of scale. The BrainGate system, for example, consists of 100 micro-electrodes in a square array; compare that to the many tens of billions of neurons in the brain. The fact these devices work at all is perhaps more a testament to the adaptability of the human brain than to our technological prowess.

Scale models

So the challenge is to build neural interfaces on scales that better match the structures of biology. Here, we move into the world of nanotechnology. There has been much work in the laboratory to make nano-electronic structures small enough to read out the activity of a single neuron. In the 1990s, Peter Fromherz, at the Max Planck Institute for Biochemistry, was a pioneer of using silicon field effect transistors, similar to those used in commercial microprocessors, to interact with cultured neurons. In 2006, Charles Lieber’s group at Harvard succeeded in using transistors made from single carbon nanotubes – whiskers of carbon just one nanometer in diameter – to measure the propagation of single nerve pulses along the nerve fibres.

But these successes have been achieved, not in whole organisms, but in cultured nerve cells which are typically on something like the surface of a silicon wafer. It’s going to be a challenge to extend these methods into three dimensions, to interface with a living brain. Perhaps the most promising direction will be to create a 3D “scaffold” incorporating nano-electronics, and then to persuade growing nerve cells to infiltrate it to create what would in effect be cyborg tissue – living cells and inorganic electronics intimately mixed.

I have featured Charles Lieber and his work here in two recent posts: ‘Bionic’ cardiac patch with nanoelectric scaffolds and living cells on July 11, 2016 and Long-term brain mapping with injectable electronics on Sept. 22, 2016.

For anyone interested in more about the controversy regarding cochlear implants, there’s this page on the Brown University (US) website. You might also want to check out Gregor Wolbring (professor at the University of Calgary) who has written extensively on the concept of ableism (links to his work can be found at the end of this post). I have excerpted from an Aug. 30, 2011 post the portion where Gregor defines ‘ableism’,

From Gregor’s June 17, 2011 posting on the FedCan blog,

The term ableism evolved from the disabled people rights movements in the United States and Britain during the 1960s and 1970s.  It questions and highlights the prejudice and discrimination experienced by persons whose body structure and ability functioning were labelled as ‘impaired’ as sub species-typical. Ableism of this flavor is a set of beliefs, processes and practices, which favors species-typical normative body structure based abilities. It labels ‘sub-normative’ species-typical biological structures as ‘deficient’, as not able to perform as expected.

The disabled people rights discourse and disability studies scholars question the assumption of deficiency intrinsic to ‘below the norm’ labeled body abilities and the favoritism for normative species-typical body abilities. The discourse around deafness and Deaf Culture would be one example where many hearing people expect the ability to hear. This expectation leads them to see deafness as a deficiency to be treated through medical means. In contrast, many Deaf people see hearing as an irrelevant ability and do not perceive themselves as ill and in need of gaining the ability to hear. Within the disabled people rights framework ableism was set up as a term to be used like sexism and racism to highlight unjust and inequitable treatment.

Ableism is, however, much more pervasive.

You can find out more about Gregor and his work here: http://www.crds.org/research/faculty/Gregor_Wolbring2.shtml or here:
https://www.facebook.com/GregorWolbring.

Swinging from 2015 to 2016 with FrogHeart

On Thursday, Dec. 31, 2015, the bear ate me (borrowed from Joan Armatrading’s song “Eating the bear”) or, if you prefer this phrase, I had a meltdown when I lost more than 1/2 of a post that I’d worked on for hours.

There’s been a problem dogging me for some months. I will write up something and save it as a draft only to find that most of the text has been replaced by a single URL repeated several times. I have not been able to source the problem which is intermittent. (sigh)

Moving on to happier thoughts, it’s a new year. Happy 2016!

As a way of swinging into the new year, here’s a brief wrap up for 2015.

International colleagues

As always, I thank my international colleagues David Bruggeman (Pasco Phronesis blog), Dexter Johnson (Nanoclast blog on the IEEE [International Electrical and Electronics Engineers website]), and Dr. Andrew Maynard (2020 science blog and Risk Innovation Laboratory at Arizona State University), all of whom have been blogging as long or longer than I have (FYI, FrogHeart began in April/May 2008). More importantly, they have been wonderful sources of information and inspiration.

In particular, David, thank you for keeping me up to date on the Canadian and international science policy situations. Also, darn you for scooping me on the Canadian science policy scene, on more than one occasion.

Dexter, thank you for all those tidbits about the science and the business of nanotechnology that you tuck into your curated blog. There’s always a revelation or two to be found in your writings.

Andrew, congratulations on your move to Arizona State University (from the University of Michigan Risk Science Center) where you are founding their Risk Innovation Lab.

While Andrew’s blog has become more focused on the topic of risk, Andrew continues to write about nanotechnology by extending the topic to emerging technologies.

In fact, I have a Dec. 3, 2015 post featuring a recent Nature article by Andrew on the occasion of the upcoming 2016 World Economic Forum in Davos. In it he discusses new approaches to risk as occasioned by the rise of emerging technologies such synthetic biology, nanotechnology, and more.

While Tim Harper, serial entrepreneur and scientist, is not actively blogging about nanotechnology these days, his writings do pop up in various places, notably on the Azonano website where he is listed as an expert, which he most assuredly is. His focus these days is in establishing graphene-based startups.

Moving on to another somewhat related topic. While no one else seems to be writing about nanotechnology as extensively as I do, there are many, many Canadian science bloggers.

Canadian colleagues

Thank you to Gregor Wolbring, ur Canadian science blogger and professor at the University of Calgary. His writing about human enhancement has become increasingly timely as we continue to introduce electronics onto and into our bodies. While he writes regularly, I don’t believe he’s blogging regularly. However, you can find out more about Gregor and his work  at  http://www.crds.org/research/faculty/Gregor_Wolbring2.shtml
or on his facebook page
https://www.facebook.com/GregorWolbring

Science Borealis (scroll down to get to the feeds), a Canadian science blog aggregator, is my main source of information on the Canadian scene. Thank you for my second Editors Pick award. In 2014 the award was in the Science in Society category and in 2015 it’s in the Engineering & Tech category (last item on the list).

While I haven’t yet heard about the results of Paige Jarreau’s and Science Borealis’ joint survey on the Canadian science blog readers (the reader doesn’t have to be Canadian but the science blog has to be), I was delighted to be asked and to participate. My Dec. 14, 2015 posting listed preliminary results,

They have compiled some preliminary results:

  • 21 bloggers + Science Borealis hosted the survey.
  • 523 respondents began the survey.
  • 338 respondents entered their email addresses to win a prize
  • 63% of 400 Respondents are not science bloggers
  • 56% of 402 Respondents describe themselves as scientists
  • 76% of 431 Respondents were not familiar with Science Borealis before taking the survey
  • 85% of 403 Respondents often, very often or always seek out science information online.
  • 59% of 402 Respondents rarely or never seek science content that is specifically Canadian
  • Of 400 Respondents, locations were: 35% Canada, 35% US, 30% Other.

And most of all, a heartfelt thank you to all who read this blog.

FrogHeart and 2015

There won’t be any statistics from the software packaged with my  hosting service (AWSTATS and Webalizer). Google and its efforts to minimize spam (or so it claims) had a devastating effect on my visit numbers. As I used those numbers as motivation, fantasizing that my readership was increasing, I had to find other means for motivation and am not quite sure how I did it but I upped publication to three posts per day (five-day week) throughout most of the year.

With 260 working days (roughly) in a year that would have meant a total of 780 posts. I’ve rounded that down to 700 posts to allow for days off and days where I didn’t manage three.

In 2015 I logged my 4000th post and substantially contributed to the Science Borealis 2015 output. In the editors’ Dec. 20, 2015 post,

… Science Borealis now boasts a membership of 122 blogs  — about a dozen up from last year. Together, this year, our members have posted over 4,400 posts, with two weeks still to go….

At a rough guess, I’d estimate that FrogHeart was responsible for 15% of the Science Borealis output and 121 bloggers were responsible for the other 85%.

That’s enough for 2015.

FrogHeart and 2016

Bluntly, I do not know anything other than a change of some sort is likely.

Hopefully, I will be doing more art/science projects (my last one was ‘A digital poetry of gold nanoparticles’). I was awarded a small grant ($400 CAD) from the Canadian Academy of Independent Scholars (thank you!) for a spoken word project to be accomplished later this year.

As for this blog, I hope to continue.

In closing, I think it’s only fair to share Joan Armatrading’s song, ‘Eating the bear’. May we all do so in 2016,

Bonne Année!

Fixed: The Science/Fiction of Human Enhancement

First the news, Fixed: The Science/Fiction of Human Enhancement is going to be broadcast on KCTS 9 (PBS [Public Broadcasting Service] station for Seattle/Yakima) on Wednesday, Aug. 26, 2015 at 7 pm PDT. From the KCTS 9 schedule,

From botox to bionic limbs, the human body is more “upgradeable” than ever. But how much of it can we alter and still be human? What do we gain or lose in the process? Award-winning documentary, Fixed: The Science/Fiction of Human Enhancement, explores the social impact of human biotechnologies. Haunting and humorous, poignant and political, Fixed rethinks “disability” and “normalcy” by exploring technologies that promise to change our bodies and minds forever.

This 2013 documentary has a predecessor titled ‘Fixed’, which I wrote about in an August 3, 2010 posting. The director for both ‘Fixeds’ is Regan Brashear.

It seems the latest version of Fixed builds on the themes present in the first, while integrating the latest scientific work (to 2013) in the field of human enhancement (from my August 3, 2010 posting),

As for the film, I found this at the University of California, Santa Cruz,

Fixed is a video documentary that explores the burgeoning field of “human enhancement” technologies from the perspective of individuals with disabilities. Fixed uses the current debates surrounding human enhancement technologies (i.e. bionic limbs, brain machine interfaces, prenatal screening technologies such as PGD or pre-implantation genetic diagnosis, etc.) to tackle larger questions about disability, inequality, and citizenship. This documentary asks the question, “Will these technologies ‘liberate’ humanity, or will they create even more inequality?”

You can find out more about the 2013 Fixed on its website or Facebook page (they list opportunities in the US, in Canada, and internationally to see the documentary). There is also a listing of PBS broadcasts available from the Fixed: The Science/Fiction of Human Enhancement Press page.

I recognized two names from the cast list on the Internet Movie Database (IMDB) page for Fixed: The Science/Fiction of Human Enhancement, Gregor Wolbring (he also appeared in the first ‘Fixed’) and Hugh Herr.

Gregor has been mentioned here a few times in connection with human enhancement. A Canadian professor at the University of Calgary, he’s active in the field of bioethics and you can find out more about Gregor and his work here.

Hugh Herr was first mentioned here in a January 30, 2013 posting titled: The ultimate DIY: ‘How to build a robotic man’ on BBC 4. He is a robotocist at the Massachusetts Institute of Technology (MIT).

The two men offering contrasting perspectives, Gregor Wolbring, ‘we should re-examine the notion that some people are impaired and need to be fixed’,  and Hugh Herr, ‘we will eliminate all forms of impairment’. Hopefully, the 2013 documentary has managed to present more of the nuances than I have.

Chemistry of Cyborgs: review of the state of the art by German researchers

Communication between man and machine – a fascinating area at the interface of chemistry, biomedicine, and engineering. (Figure: KIT/S. Giselbrecht, R. Meyer, B. Rapp)

Communication between man and machine – a fascinating area at the interface of chemistry, biomedicine, and engineering. (Figure: KIT/S. Giselbrecht, R. Meyer, B. Rapp)

German researchers from the Karlsruhe Institute of Technology (KIT), Professor Christof M. Niemeyer and Dr. Stefan Giselbrecht of the Institute for Biological Interfaces 1 (IBG 1) and Dr. Bastian E. Rapp, Institute of Microstructure Technology (IMT) have written a good overview of the current state of cyborgs while pointing out some of the ethical issues associated with this field. From the Jan. 10, 2014 news item on ScienceDaily,

Medical implants, complex interfaces between brain and machine or remotely controlled insects: Recent developments combining machines and organisms have great potentials, but also give rise to major ethical concerns. In a new review, KIT scientists discuss the state of the art of research, opportunities, and risks.

The Jan. ?, 2014 KIT press release (also on EurekAlert with a release date of Jan. 10, 2014), which originated the news item, describes the innovations and the work at KIT in more detail,

They are known from science fiction novels and films – technically modified organisms with extraordinary skills, so-called cyborgs. This name originates from the English term “cybernetic organism”. In fact, cyborgs that combine technical systems with living organisms are already reality. The KIT researchers Professor Christof M. Niemeyer and Dr. Stefan Giselbrecht of the Institute for Biological Interfaces 1 (IBG 1) and Dr. Bastian E. Rapp, Institute of Microstructure Technology (IMT), point out that this especially applies to medical implants.

In recent years, medical implants based on smart materials that automatically react to changing conditions, computer-supported design and fabrication based on magnetic resonance tomography datasets or surface modifications for improved tissue integration allowed major progress to be achieved. For successful tissue integration and the prevention of inflammation reactions, special surface coatings were developed also by the KIT under e.g. the multidisciplinary Helmholtz program “BioInterfaces”.

Progress in microelectronics and semiconductor technology has been the basis of electronic implants controlling, restoring or improving the functions of the human body, such as cardiac pacemakers, retina implants, hearing implants, or implants for deep brain stimulation in pain or Parkinson therapies. Currently, bioelectronic developments are being combined with robotics systems to design highly complex neuroprostheses. Scientists are working on brain-machine interfaces (BMI) for the direct physical contacting of the brain. BMI are used among others to control prostheses and complex movements, such as gripping. Moreover, they are important tools in neurosciences, as they provide insight into the functioning of the brain. Apart from electric signals, substances released by implanted micro- and nanofluidic systems in a spatially or temporarily controlled manner can be used for communication between technical devices and organisms.

BMI are often considered data suppliers. However, they can also be used to feed signals into the brain, which is a highly controversial issue from the ethical point of view. “Implanted BMI that feed signals into nerves, muscles or directly into the brain are already used on a routine basis, e.g. in cardiac pacemakers or implants for deep brain stimulation,” Professor Christof M. Niemeyer, KIT, explains. “But these signals are neither planned to be used nor suited to control the entire organism – brains of most living organisms are far too complex.”

Brains of lower organisms, such as insects, are less complex. As soon as a signal is coupled in, a certain movement program, such as running or flying, is started. So-called biobots, i.e. large insects with implanted electronic and microfluidic control units, are used in a new generation of tools, such as small flying objects for monitoring and rescue missions. In addition, they are applied as model systems in neurosciences in order to understand basic relationships.

Electrically active medical implants that are used for longer terms depend on reliable power supply. Presently, scientists are working on methods to use the patient body’s own thermal, kinetic, electric or chemical energy.

In their review the KIT researchers sum up that developments combining technical devices with organisms have a fascinating potential. They may considerably improve the quality of life of many people in the medical sector in particular. However, ethical and social aspects always have to be taken into account.

After briefly reading the paper, I can say the researchers are most interested in the science and technology aspects but they do have this to say about ethical and social issues in the paper’s conclusion (Note: Links have been removed),

The research and development activities summarized here clearly raise significant social and ethical concerns, in particular, when it comes to the use of BMIs for signal injection into humans, which may lead to modulation or even control of behavior. The ethical issues of this new technology have been discussed in the excellent commentary of Jens Clausen,33 which we highly recommend for further reading. The recently described engineering of a synthetic polymer construct, which is capable of propulsion in water through a collection of adhered rat cardiomyocytes,77 a “medusoid” also described as a “cyborg jellyfish with a rat heart”, brings up an additional ethical aspect. The motivation of the work was to reverse-engineer muscular pumps, and it thus represents fundamental research in tissue engineering for biomedical applications. However, it is also an impressive, early demonstration that autonomous control of technical devices can be achieved through small populations of cells or microtissues. It seems reasonable that future developments along this line will strive, for example, to control complex robots through the use of brain tissue. Given the fact that the robots of today are already capable of autonomously performing complex missions, even in unknown territories,78 this approach might indeed pave the way for yet another entirely new generation of cybernetic organisms.

Here’s a link to and a citation for the English language version of the paper, which is open access (as of Jan. 10, 2014),

The Chemistry of Cyborgs—Interfacing Technical Devices with Organisms by Dr. Stefan Giselbrecht, Dr. Bastian E. Rapp, & Prof.Dr. Christof M. Niemeyer. Angewandte Chemie International Edition Volume 52, Issue 52, pages 13942–13957, December 23, 2013 Article first published online: 29 NOV 2013 DOI: 10.1002/anie.201307495

Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

For those with German language skills,

Chemie der Cyborgs – zur Verknüpfung technischer Systeme mit Lebewesen.  by Stefan Giselbrecht, Bastian E. Rapp, and Christof M. Niemeyer. Angewandte Chemie. Volume 125, issue 52, pages 14190, December 23, 2013. DOI: 10.1002/ange.201307495

I have written many times about cyborgs and neuroprosthetics including this Aug. 30, 2011 posting titled:  Eye, arm, & leg prostheses, cyborgs, eyeborgs, Deus Ex, and ableism, where I mention Gregor Wolbring, a Canadian academic (University of Calgary) who has written extensively on the social and ethical issues of human enhancement technologies. You can find out more on his blog, Nano and Nano- Bio, Info, Cogno, Neuro, Synbio, Geo, Chem…

For anyone wanting to search this blog for these pieces, try using the term machine/flesh as a tag, as well as, human enhancement, neuroprostheses, cyborgs …

Almost Human (tv series), smartphones, and anxieties about life/nonlife

The US-based Fox Broadcasting Company is set to premiere a new futuristic television series, Almost Human, over two nights, Nov. 17, and 18, 2013 for US and Canadian viewers. Here’s a description of the premise from its Wikipedia essay (Note: Links have been removed),

The series is set thirty-five years in the future when humans in the Los Angeles Police Department are paired up with lifelike androids; a detective who has a dislike for robots partners with an android capable of emotion.

One of the showrunners, Naren Shankar, seems to have also been functioning both as a science consultant and as a crime writing consultant,in addition to his other duties. From a Sept. 4, 2013 article by Lisa Tsering for Indiawest.com,

FOX is the latest television network to utilize the formidable talents of Naren Shankar, an Indian American writer and producer best known to fans for his work on “Star Trek: Deep Space Nine,” “Star Trek: Voyager” and “Star Trek: The Next Generation” as well as “Farscape,” the recently cancelled ABC series “Zero Hour” and “The Outer Limits.”

Set 35 years in the future, “Almost Human” stars Karl Urban and Michael Ealy as a crimefighting duo of a cop who is part-machine and a robot who is part-human. [emphasis mine]

“We are extrapolating the things we see today into the near future,” he explained. For example, the show will comment on the pervasiveness of location software, he said. “There will also be issues of technology such as medical ethics, or privacy; or how technology enables the rich but not the poor, who can’t afford it.”

Speaking at Comic-Con July 20 [2013], Shankar told media there, “Joel [J.H. Wyman] was looking for a collaboration with someone who had come from the crime world, and I had worked on ‘CSI’ for eight years.

“This is like coming back to my first love, since for many years I had done science fiction. It’s a great opportunity to get away from dismembered corpses and autopsy scenes.”

There’s plenty of drama — in the new series, the year is 2048, and police officer John Kennex (Karl Urban, “Dr. Bones” from the new “Star Trek” films) is trying to bounce back from one of the most catastrophic attacks ever made against the police department. Kennex wakes up from a 17-month coma and can’t remember much, except that his partner was killed; his girlfriend left him and one of his legs has been amputated and is now outfitted with a high-tech synthetic appendage. According to police department policy, every cop must partner with a robot, so Kennex is paired with Dorian (Ealy), an android with an unusual glitch that makes it have human emotions.

Shankar took an unusual path into television. He started college at age 16 and attended Cornell University, where he earned a B. Sc., an M.S. and a Ph.D. in engineering physics and electrical engineering, and was a member of the elite Kappa Alpha Society, he decided he didn’t want to work as a scientist and moved to Los Angeles to try to become a writer.

Shankar is eager to move in a new direction with “Almost Human,” which he says comes at the right time. “People are so technologically sophisticated now that maybe the audience is ready for a show like this,” he told India-West.

I am particularly intrigued by the ‘man who’s part machine and the machine that’s part human’ concept (something I’ve called machine/flesh in previous postings such as this May 9, 2012 posting titled ‘Everything becomes part machine’) and was looking forward to seeing how they would be integrating this concept along with some of the more recent scientific work being done on prosthetics and robots, given they had an engineer as part of the team (albeit with lots of crime writing experience), into the stories. Sadly, only days after Tserling’s article was published, Shankar parted ways with Almost Human according to the Sept. 10, 2013 posting on the Almost Human blog,

So this was supposed to be the week that I posted a profile of Naren Shankar, for whom I have developed a full-on crush–I mean, he has a PhD in Electrical Engineering from Cornell, he was hired by Gene Roddenberry to be science consultant on TNG, he was saying all sorts of great things about how he wanted to present the future in AH…aaaand he quit as co-showrunner yesterday, citing “creative differences.” That leaves Wyman as sole showrunner, with no plans to replace Shankar.

I’d like to base some of my comments on the previews, unfortunately, Fox Broadcasting,, in its infinite wisdom, has decided to block Canadians from watching Almost Human previews online. (Could someone please explain why? I mean, Canadians will be tuning in to watch or record for future viewing  the series premiere on the 17th & 18th of November 2013 just like our US neighbours, so, why can’t we watch the previews online?)

Getting back to machine/flesh (human with prosthetic)s and life/nonlife (android with feelings), it seems that Almost Human (as did the latest version of Battlestar Galactica, from 2004-2009) may be giving a popular culture voice to some contemporary anxieties being felt about the boundary or lack thereof between humans and machines and life/nonlife. I’ve touched on this topic many times both within and without the popular culture context. Probably one of my more comprehensive essays on machine/flesh is Eye, arm, & leg prostheses, cyborgs, eyeborgs, Deus Ex, and ableism from August 30, 2011, which includes this quote from a still earlier posting on this topic,

Here’s an excerpt from my Feb. 2, 2010 posting which reinforces what Gregor [Gregor Wolbring, University of Calgary] is saying,

This influx of R&D cash, combined with breakthroughs in materials science and processor speed, has had a striking visual and social result: an emblem of hurt and loss has become a paradigm of the sleek, modern, and powerful. Which is why Michael Bailey, a 24-year-old student in Duluth, Georgia, is looking forward to the day when he can amputate the last two fingers on his left hand.

“I don’t think I would have said this if it had never happened,” says Bailey, referring to the accident that tore off his pinkie, ring, and middle fingers. “But I told Touch Bionics I’d cut the rest of my hand off if I could make all five of my fingers robotic.” [originally excerpted from Paul Hochman’s Feb. 1, 2010 article, Bionic Legs, i-Limbs, and Other Super Human Prostheses You’ll Envy for Fast Company]

Here’s something else from the Hochman article,

But Bailey is most surprised by his own reaction. “When I’m wearing it, I do feel different: I feel stronger. As weird as that sounds, having a piece of machinery incorporated into your body, as a part of you, well, it makes you feel above human. [semphasis mine] It’s a very powerful thing.”

Bailey isn’t  almost human’, he’s ‘above human’. As Hochman points out. repeatedly throughout his article, this sentiment is not confined to Bailey. My guess is that Kennex (Karl Urban’s character) in Almost Human doesn’t echo Bailey’s sentiments and, instead feels he’s not quite human while the android, Dorian, (Michael Ealy’s character) struggles with his feelings in a human way that clashes with Kennex’s perspective on what is human and what is not (or what we might be called the boundary between life and nonlife).

Into this mix, one could add the rising anxiety around ‘intelligent’ machines present in real life, as well as, fiction as per this November 12 (?), 2013 article by Ian Barker for Beta News,

The rise of intelligent machines has long been fertile ground for science fiction writers, but a new report by technology research specialists Gartner suggests that the future is closer than we think.

“Smartphones are becoming smarter, and will be smarter than you by 2017,” says Carolina Milanesi, research vice president at Gartner. “If there is heavy traffic, it will wake you up early for a meeting with your boss, or simply send an apology if it is a meeting with your colleague. The smartphone will gather contextual information from its calendar, its sensors, the user’s location and personal data”.

Your smartphone will be able to predict your next move or your next purchase based on what it knows about you. This will be made possible by gathering data using a technique called “cognizant computing”.

Gartner analysts will be discussing the future of smart devices at the Gartner Symposium/ITxpo 2013 in Barcelona from November 10-14 [2013].

The Gartner Symposium/Txpo in Barcelona is ending today (Nov. 14, 2013) but should you be curious about it, you can go here to learn more.

This notion that machines might (or will) get smarter or more powerful than humans (or wizards) is explored by Will.i.am (of the Black Eyed Peas) and, futurist, Brian David Johnson in their upcoming comic book, Wizards and Robots (mentioned in my Oct. 6, 2013 posting),. This notion of machines or technology overtaking human life is also being discussed at the University of Cambridge where there’s talk of founding a Centre for the Study of Existential Risk (from my Nov. 26, 2012 posting)

The idea that robots of one kind or another (e.g. nanobots eating up the world and leaving grey goo, Cylons in both versions of Battlestar Galactica trying to exterminate humans, etc.) will take over the world and find humans unnecessary  isn’t especially new in works of fiction. It’s not always mentioned directly but the underlying anxiety often has to do with intelligence and concerns over an ‘explosion of intelligence’. The question it raises,’ what if our machines/creations become more intelligent than humans?’ has been described as existential risk. According to a Nov. 25, 2012 article by Sylvia Hui for Huffington Post, a group of eminent philosophers and scientists at the University of Cambridge are proposing to found a Centre for the Study of Existential Risk,

Could computers become cleverer than humans and take over the world? Or is that just the stuff of science fiction?

Philosophers and scientists at Britain’s Cambridge University think the question deserves serious study. A proposed Center for the Study of Existential Risk will bring together experts to consider the ways in which super intelligent technology, including artificial intelligence, could “threaten our own existence,” the institution said Sunday.

“In the case of artificial intelligence, it seems a reasonable prediction that some time in this or the next century intelligence will escape from the constraints of biology,” Cambridge philosophy professor Huw Price said.

When that happens, “we’re no longer the smartest things around,” he said, and will risk being at the mercy of “machines that are not malicious, but machines whose interests don’t include us.”

Our emerging technologies give rise to questions abut what constitutes life and where human might fit in. For example,

  • are sufficiently advanced machines a new form of life,?
  • what does it mean when human bodies are partially integrated at the neural level with machinery?
  • what happens when machines have feelings?
  • etc.

While this doesn’t exactly fit into my theme of life/nonlife or machine/flesh, this does highlight how some popular culture efforts are attempting to integrate real science into the storytelling. Here’s an excerpt from an interview with Cosima Herter, the science consultant and namesake/model for one of the characters on Orphan Black (from the March 29, 2013 posting on the space.ca blog),

Cosima Herter is Orphan Black’s Science Consultant, and the inspiration for her namesake character in the series. In real-life, Real Cosima is a PhD. student in the History of Science, Technology, and Medicine Program at the University of Minnesota, working on the History and Philosophy of Biology. Hive interns Billi Knight & Peter Rowley spoke with her about her role on the show and the science behind it…

Q: Describe your role in the making of Orphan Black.

A: I’m a resource for the biology, particularly insofar as evolutionary biology is concerned. I study the history and the philosophy of biology, so I do offer some suggestions and some creative ideas, but also help correct some of the misconceptions about science.  I offer different angles and alternatives to look at the way biological science is represented, so (it’s) not reduced to your stereotypical tropes about evolutionary biology and cloning, but also to provide some accuracy for the scripts.

– See more at: http://www.space.ca/article/Orphan-Black-science-consultant#sthash.7P36bbPa.dpuf

For anyone not familiar with the series, from the Wikipedia essay (Note: Links have been removed),

Orphan Black is a Canadian science fiction television series starring Tatiana Maslany as several identical women who are revealed to be clones.

The ultimate DIY: ‘How to build a robotic man’ on BBC 4

British Broadcasting Corporation’s Channel 4 (BBC 4) will be telecasting the ultimate do-it-yourself (DIY) project, How to build a bionic man on Feb. 7, 2013, 9 pm GMT. Corinne Burns in a Jan. 30, 2013 posting for the Guardian science blogs describes the documentary (Note: Links have been removed),

Created by Darlow Smithson Productions (DSP, the TV company behind Touching The Void and Richard Hammond’s Engineering Connections), with the help of robotics experts Shadow Robot Company, the bionic man was conceived as a literal response to the question: how close is bionic technology is to catching up with – and even exceeding – the capabilities of the human body?

DSP got in touch with Dr Bertolt Meyer, a charismatic young researcher from Zurich University and himself a lifelong user of prosthetic technology, and invited him to, essentially, rebuild himself in bionic form. The result can be seen in How to Build a Bionic Man, to be broadcast on Channel 4 on 7 February. The Bionic Man himself will then reside in the Science Museum’s Who Am I? gallery from 7 February until 11 March.

Richard Walker (left), chief roboticist, and Dr Bertolt Meyer (right) at the Body Lab. On the table is an iWalk BiOM ankle. Photograph: Channel 4  [downloaded from http://www.guardian.co.uk/science/blog/2013/jan/30/build-bionic-man]

Richard Walker (left), chief roboticist, and Dr Bertolt Meyer (right) at the Body Lab. On the table is an iWalk BiOM ankle. Photograph: Channel 4 [downloaded from http://www.guardian.co.uk/science/blog/2013/jan/30/build-bionic-man]

Burns goes on to discuss some of the issues raised by the increasing sophistication of prosthetics (Note: Links have been removed),

The engineering behind modern prosthetics is certainly awe-inspiring. The iLimb Ultra, of which Bertolt is a user, is part of the new class of myoelectric prosthetics. These custom-made devices function by placing electrical sensors directly in contact with the skin. These sensors pick up the signals generated by muscular movements in the residual limb – signals that are then translated by software into natural, intuitive movement in the prosthetic limb.

We all know about prosthetic limbs, even if many of us are not aware of just how sophisticated they now are. Less familiar, though, is the idea of bionic organs. Far removed from the iron lung of yore, these new fully integrated artificial body parts are designed to plug directly into our own metabolism – in effect, they are not within us, they become us. They’re the ultimate in biomimicry.

It’s one thing to use a bionic organ to replace lost function. But in a future world where we could, feasibly, replace virtually all of our body, will we blur the boundaries of artificial and natural to an extent that we have to recalibrate our definition of self and non-self? That’s especially pertinent when we consider the reality of neural prosthetics, like the “memory chips” developed by Dr Theodore Berger. Instinctively, many of us are uncomfortable with brain implants – but should we be? And will this discomfort be reduced if we broaden our definition of self?

Bertolt himself is pleased with the increasing normalisation, and even “coolness”, of prosthetics. But he expresses caution about the potential for elective use of such technology – would we ever choose to remove a healthy body part, in order to replace it with a stronger, better prosthetic?

Burns’ posting isn’t the only place where these discussion points and others related to human enhancement and robotic technologies are being raised, in a Jan. 18, 2013 posting I mentioned *a television advertisement for a new smartphone that ‘upgrades your brain’ that ‘normalises’ the idea of brain implants and other enhancements for everybody. As well, The Economist recently featured an article, You, robot? in its September 1st – 7th, 2012 issue about the European Union’s RoboLaw Project,

SPEAKING at a conference organised by The Economist earlier this year [2012], Hugh Herr, a roboticist at the Massachusetts Institute of Technology, described disabilities as conditions that persist “because of poor technology” and made the bold claim that during the 21st century disability would be largely eliminated. What gave his words added force was that half way through his speech, after ten minutes of strolling around the stage, he unexpectedly pulled up his trouser legs to reveal his bionic legs, and then danced a little jig. In future, he suggested, people might choose to replace an arthritic, painful limb with a fully functional robotic one. “Why wouldn’t you replace it?” he asked. “We’re going to see a lot of unusual situations like that.”

It is precisely to consider these sorts of situations, and the legal and ethical conundrums they will pose, that a new research project was launched in March. Is a prosthetic legally part of your body? When is it appropriate to amputate a limb and replace it with a robotic one? What are the legal rights of a person with “locked in” syndrome who communicates via a brain-computer interface? Do brain implants and body-enhancement devices require changes to the definition of disability? The RoboLaw project is an effort to anticipate such quandaries and work out where and how legal frameworks might need to be changed as the technology of bionics and neural interfaces improves. Funded to the tune of €1.9m ($2.3m), of which €1.4m comes from the European Commission, it brings together experts from engineering, law, regulation, philosophy and human enhancement.

There have been some recent legal challenges as to what constitutes one’s body (from The Economist article, You, robot?),

If you are dependent on a robotic wheelchair for mobility, for example, does the wheelchair count as part of your body? Linda MacDonald Glenn, an American lawyer and bioethicist, thinks it does. Ms Glenn (who is not involved in the RoboLaw project) persuaded an initially sceptical insurance firm that a “mobility assistance device” damaged by airline staff was more than her client’s personal property, it was an extension of his physical body. The airline settled out of court.

RoboLaw is a European Union Framework Programme 7-funded two year project, which started in 2012. There is a conference to be held in the Netherlands, April 23 – 24, 2013, from the RoboLaw home page,

RoboLaw Authors Workshop and Volume on ‘Opportunities and risks of robotics in relation to human values’

23-24 April 2013, Tilburg University, Tilburg (The Netherlands)

Call for paper and participation. Robotic technologies, taken to encompass anything from ‘traditional’ robots to emerging technologies in the field of biomedical research, such as nanotechnologies, bionics, and neural interfaces, as well as innovative biomedical applications, such as biomechatronic prostheses, hybrid bionic systems and bio- mechatronic components for sensory and motor augmentation, will have a profound impact on our lives. They may also affect human values, such as privacy, autonomy, bodily integrity, health, etc. In this workshop, we will focus on the impact of new technologies, and particularly robotics, on fundamental rights and human values. …

Important dates
Before 1 January 2013: Send an email to Ronald Leenes confirming your attendance, expressing your intention to either submit a paper or act as a commentator/reviewer.
Before 1 February: Send a 300 word abstract of the intended paper to Ronald Leenes
Before 8 February: Notification of acceptance.
Before 1 March: If your abstract has been accepted, send a draft of your full paper in PDF format to Ronald Leenes
Before 5 March: Circulation of papers
23-24 April 2013: Workshop
10 May: Selected final papers to be handed in.

According to the schedule, it’s a bit late to start the process for submitting an abstract but it never hurts to try.

Canadian academic, Gregor Wolbring, assistant professor, Dept of Community Health Sciences, Program in Community Rehabilitation and Disability Studies at the University of Calgary and past president of the Canadian Disability Studies Association, offers a nuanced perspective on human enhancement issues and the term, ableism. From my Aug. 30, 2011 posting on cyborgs, eyeborgs and others,

… Gregor’s June 17, 2011 posting on the FedCan blog,

The term ableism evolved from the disabled people rights movements in the United States and Britain during the 1960s and 1970s.  It questions and highlights the prejudice and discrimination experienced by persons whose body structure and ability functioning were labelled as ‘impaired’ as sub species-typical. Ableism of this flavor is a set of beliefs, processes and practices, which favors species-typical normative body structure based abilities. It labels ‘sub-normative’ species-typical biological structures as ‘deficient’, as not able to perform as expected.

The disabled people rights discourse and disability studies scholars question the assumption of deficiency intrinsic to ‘below the norm’ labeled body abilities and the favoritism for normative species-typical body abilities. The discourse around deafness and Deaf Culture would be one example where many hearing people expect the ability to hear. This expectation leads them to see deafness as a deficiency to be treated through medical means. In contrast, many Deaf people see hearing as an irrelevant ability and do not perceive themselves as ill and in need of gaining the ability to hear. Within the disabled people rights framework ableism was set up as a term to be used like sexism and racism to highlight unjust and inequitable treatment.

Ableism is, however, much more pervasive.

Ableism based on biological structure is not limited to the species-typical/ sub species-typical dichotomy. With recent science and technology advances, and envisioned advances to come, we will see the dichotomy of people exhibiting species-typical and the so-called sub species-typical abilities labeled as impaired, and in ill health. On the other side we will see people exhibiting beyond species-typical abilities as the new expectation norm. An ableism that favours beyond species-typical abilities over species-typical and sub species-typical abilities will enable a change in meaning and scope of concepts such as health, illness, rehabilitation, disability adjusted life years, medicine, health care, and health insurance. For example, one will only be labeled as healthy if one has received the newest upgrade to one’s body – meaning one would by default be ill until one receives the upgrade.

You can find more about Gregor’s work on his University of Calgary webpage or his blog.

Finally, for anyone who wants a look at BBC 4’s ‘biionic man’,

A television company asked Dr Bertolt Meyer – who has a prosthetic arm – to rebuild himself in bionic form. Photograph: Channel 4 [downloaded from http://www.guardian.co.uk/science/blog/2013/jan/30/build-bionic-man]

A television company asked Dr Bertolt Meyer – who has a prosthetic arm – to rebuild himself in bionic form. Photograph: Channel 4 [downloaded from http://www.guardian.co.uk/science/blog/2013/jan/30/build-bionic-man]

* The articles ‘an’ was corrected to ‘a’ on July 16, 2013.